|
Home
Search
Study Topics
Glossary
|
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
![]() |
||||||||||||||||||||||||||||||||||||
| Sponsor: | Assistance Publique - Hôpitaux de Paris |
|---|---|
| Information provided by: | Assistance Publique - Hôpitaux de Paris |
| ClinicalTrials.gov Identifier: | NCT00470080 |
Purpose
This randomized bicentric trial will investigate the efficacy of topical EMLA cream with oral sucrose solution compared to oral sucrose solution alone before venepuncture in preterm infants.
| Condition | Intervention | Phase |
|---|---|---|
|
Pain |
Procedure: venepuncture |
Phase IV |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Endpoint Classification: Efficacy Study Intervention Model: Parallel Assignment Masking: Double Blind (Subject, Investigator) Primary Purpose: Treatment |
| Official Title: | Randomised Trial of Eutectic Mixture of Local Anaesthetics Cream and Oral Sucrose Solution for Venepuncture in Preterm Infants |
| Enrollment: | 80 |
| Study Start Date: | June 2007 |
| Study Completion Date: | November 2007 |
| Primary Completion Date: | November 2007 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
|
Experimental: 1
venepuncture
|
Procedure: venepuncture
venepuncture
Other Name: venepuncture
|
Venepuncture is a painful procedure commonly performed in premature infants. Nonpharmacological intervention (oral sucrose solution) can reduce neonatal pain. EMLA cream is an oil in water emulsion of an eutectic mixture of prilocaine and lignocaine; it is an local anesthetic cream. Very few reports have looked at the efficacy of EMLA in preterm infants.
This randomized bicentric trial will investigate the efficacy of topical EMLA cream with oral sucrose solution compared to oral sucrose solution alone before venepuncture in preterm infants.
Eligibility| Ages Eligible for Study: | 26 Weeks to 37 Weeks |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
Contacts and Locations
More Information
| Responsible Party: | Yannick VACHER, Department Clinical Research of developpement |
| ClinicalTrials.gov Identifier: | NCT00470080 History of Changes |
| Other Study ID Numbers: | P060501 |
| Study First Received: | May 4, 2007 |
| Last Updated: | May 3, 2011 |
| Health Authority: | France: Ministry of Health |
|
Venepuncture Pain Emla cream Oral sucrose solution |
Premature infant Premature infant admitted to the care baby unit were included in the study. Programed venepuncture is performed with analgesia. |
|
Anesthetics, Local EMLA Lidocaine Prilocaine Anesthetics Central Nervous System Depressants Physiological Effects of Drugs Pharmacologic Actions |
Sensory System Agents Peripheral Nervous System Agents Central Nervous System Agents Therapeutic Uses Anesthetics, Combined Anti-Arrhythmia Agents Cardiovascular Agents |